Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group trial13-93
Colleoni M, Gelber S, Goldhirsch A, et al: Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group trial13-93. J Clin Oncol 24:1332-1341, 2006
Incidence, time course and determinants of menstrual bleeding after breast cancer treatment: A prospective study
Petrek JA, Naughton MJ, Case LD, et al: Incidence, time course and determinants of menstrual bleeding after breast cancer treatment: A prospective study. J Clin Oncol 24:1045-1051, 2006
Amenorrhea in premenopausal women on the doxorubicin (A) and cyclophosphamide (C) -> docetaxel (T) arm of NSABP B-30: Preliminary results
suppl: abstr 537, 13s
Swain SM, Land SR, Sundry R et al: Amenorrhea in premenopausal women on the doxorubicin (A) and cyclophosphamide (C) -> docetaxel (T) arm of NSABP B-30: Preliminary results. J Clin Oncol 23:13s, 2005 (suppl: abstr 537)
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: Results of a multicentric Italian study- Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group
Boccardo F, Rubagotti A, Bruzzi P, et al: Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: Results of a multicentric Italian study- Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group. J Clin Oncol 8:1310-1320, 1990